Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Biochemical Pharmacology|February 5, 1999
Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell linesC J van Moorsel, H M Pinedo, G Veerman, et al.Nucleosides, Nucleotides & Nucleic Acids|October 27, 2006
Micro-array analysis of resistance for gemcitabine results in increased expression of ribonucleotide reductase subunitsK Smid, A M Bergman, P P Eijk, et al.Nucleosides & Nucleotides|August 5, 1999
Cell specific cytotoxicity and structure-activity relationship of lipophilic 1-B-D-arabinofuranosylcytosine (ara-C) derivativesG J Peters, D A Voorn, C M Kuiper, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2005
Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenaseC H Smorenburg, G J Peters, C J van Groeningen, et al.British Journal of Cancer|November 2, 2013
Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxiaM Maftouh, A Avan, R Sciarrillo, et al.Journal of Crohn'S & Colitis|January 16, 2013
The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: results from a prospective pharmacological studyM L Seinen, D P van Asseldonk, N K H de Boer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancerB van Triest, H M Pinedo, J L Blaauwgeers, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patientsH H Backus, D F Dukers, C J van Groeningen, et al.British Journal of Cancer|October 6, 2011
Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatinE Giovannetti, P A Zucali, Y G Assaraf, et al.Nucleosides, Nucleotides & Nucleic Acids|December 2, 2004
Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenograftsA M Bergman, C M Kuiper, P Noordhuis, et al.Pageof 6